Clinical Trials Logo

Cardiovascular Diseases clinical trials

View clinical trials related to Cardiovascular Diseases.

Filter by:

NCT ID: NCT05051280 Recruiting - Clinical trials for Cardiovascular Diseases

Left Atrial Appendage Occlusion Under Cone-beam Computed Tomography Fusion Image Guidance

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

Left atrial appendage occlusion is being widely recommended as a treatment strategy for patients with nonvalvular AF to prevent stroke, especially those who cannot tolerate long-term oral anticoagulation or have other reasons for nonpharmacologic therapy. Currently, there are a number of guidance for left atrial appendage occlusion, such as transesophageal echocardiography, intracardiac echocardiogram, fluoroscopy, computed tomographic/computed tomographic angiography and so on. Procedures such as atrial septal puncture, device size selection and operational view are guided by different methods in various centers. Our center has developed a new approach to guidance: Cone-beam CT and cardiac computed tomographic angiography were combined by three-dimensional - three-dimensional image fusion in guiding left atrial appendage occlusion.

NCT ID: NCT05050266 Not yet recruiting - Obesity Clinical Trials

Enhancing Mental and Physical Health of Women Veterans

EMPOWER
Start date: November 1, 2021
Phase: N/A
Study type: Interventional

Women Veterans are the fastest growing segment of VA users. This dramatic growth has created challenges for VA to ensure that appropriate services are available to meet women Veterans' needs, and that they will want and be able to use those services. This program, EMPOWER QUERI 2.0, uses mixed methods to evaluate two strategies designed to support implementation and sustainment of three preventive evidence-based practices for women Veterans. The evidence-based practices address prevention of type 2 diabetes, cardiovascular disease, and perinatal depression, all of which are high-priority health conditions among women. The investigators will implement these evidence-based practices in 20 VA facilities across four regions; some of the facilities are rural, and some are low-performing in women's health. All three evidence-based practices will be available virtually (e.g., online, by telephone or telehealth) so that women can engage in them at their convenience. This virtual care approach is of great importance to VA because it can increase access to care and thereby improve Veterans' health outcomes.

NCT ID: NCT05049174 Not yet recruiting - Clinical trials for Cardiovascular Diseases

Nurse-led Smoking Cessation Program With Follow-up in Healthy Life Centres: a Randomized Clinical Trial

Start date: October 4, 2021
Phase: N/A
Study type: Interventional

A better understanding of how to incorporate effective smoking cessation into clinical practice is requested. In this is prospective, multi-center, randomized, open, blinded end-point trial, we assigned daily smokers hospitalized with an acute cardiac event 1:1 to an in-hospital nurse-led smoking cessation intervention with direct referral to further follow-up in the municipal healthy life-centres (intensive intervention) or to written information about smoking cessation and the municipal program (low-threshold intervention) . Both groups were prescribed varenicline from the hospital. The primary outcome will be the smoking cessation rates between the groups at 6 months follow-up. Key secondary outcomes include a cost-effectiveness analysis of the intensive intervention and cessation rates at 3- and 12-months follow-up, the proportion who used varenicline or nicotine replacement therapy and the proportion who attended the healthy-life center program between the two groups. Exploratory analyses include new knowledge about the patient and system factors of importance for participation to healthy life-centers and for changes in smoking behaviour.

NCT ID: NCT05049096 Not yet recruiting - Hypertension Clinical Trials

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension

PARADISE-HTN
Start date: October 8, 2021
Phase: N/A
Study type: Interventional

This randomized, double blinded, sham-control trial aims to evaluate the efficacy and safety of a novel focused power ultrasound mediated inferior perirenal adipose tissue modification therapy for essential hypertension.

NCT ID: NCT05047835 Recruiting - Clinical trials for Cardiovascular Diseases

Comparison of Prone Position and Standard Electrocardiogram in COVID-19 Patients

Start date: September 10, 2021
Phase:
Study type: Observational

Prolonged prone position ventilation reduces the 30-day mortality in acute respiratory distress syndrome (ARDS) and in COVID-19 infection. A large number of patients with COVID-19 suffered from new-onset cardiac disease, therefore, ECG is crucial. However, there is limited data on the effects of prone position on the ECG in COVID-19 patients.

NCT ID: NCT05044273 Not yet recruiting - Clinical trials for Coronary Artery Disease

Evaluation of Effectiveness and Safety of Synergy XD Stent

IRIS SynergyXD
Start date: October 31, 2021
Phase:
Study type: Observational [Patient Registry]

The objective of this study is to evaluate the effectiveness and safety of Synergy XD stent in the "real world" daily practice as compared with the other drug-eluting stents.

NCT ID: NCT05035758 Completed - Clinical trials for Cardiovascular Diseases

Transcendental Meditation and Yoga: Short- and Long-term Effects in Cardiac Rehabilitation Patients - a Pilot Study

TMY_Rehab
Start date: October 1, 2019
Phase: N/A
Study type: Interventional

Atherosclerotic cardiovascular disease (CVD) is the leading cause of death in Austria. The ESC guidelines recommend cardiac rehabilitation after coronary events (acute coronary syndrome, myocardial infarction, etc) with the highest level of evidence. Drug therapy and non-pharmacological measures such as a targeted and individualized exercise program, stress management programs, reduction of cardiovascular risk parameters through training, nutritional counseling, smoking cessation, etc. reduce the cardiovascular risk of recurrence. The reduction of psychosocial stress is regarded as one of the major factors in cardiac rehabilitation, alongside physical training and nutrition. In this study, transcendental meditation (TM) and yoga will be added on top of regular cardiac rehabilitation to investigate the efficiency of these methods to possibly improve the quality of life of recovering patients. Both methods are believed to reduce stress for users, while being relatively easy to introduce to and implement in daily life for beginners, carrying no extra cost for them further down the line. The main hypothesis is that cardiac patients undergoing rehabilitation plus TM or yoga therapy will show changes in endothelial function, micobiome and stress levels. Three groups of 10 participants from a cardiac cardiac rehabilitation will be subjected to standard rehabilitation, rehabilitation with meditation, and rehabilitation with yoga, respectively. The vascular state of each patient will be closely monitored over the 4 weeks, as well as after a 1-year follow up. Furthermore, the expected stress reductions will be assessed in short term and long-term by researching hair cortisol levels, on top of self-reporting questionnaires.

NCT ID: NCT05034380 Completed - Obesity Clinical Trials

Epigenetic Effects of a Single Bout of Exercise on Cardiovascular Risk Factors and the Metabolome

Start date: September 14, 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the ability of acute exercise to regulate fat metabolism in muscle of overweight and obese people compared to lean people.

NCT ID: NCT05033613 Recruiting - Pain Clinical Trials

Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease

Start date: September 10, 2021
Phase:
Study type: Observational

The coronavirus SARS-CoV-2 causing COVID-19 was pandemic since 2020. Vaccination is one of the most important measure to control the outbreak. The countries of the world started the vaccination since December, 2020. Taiwan started since March, 21st, 2021. Currently, Taiwanese people receive COVID-19 vaccination by either AZ or Moderna; Pfizer/BNT vaccine may import in the near future. The side effects post vaccination including injection site pain, fatigue, headache, myalgia, chills, arthralgia, fever, and so on. Incidence of side effects more frequent in young people than elders; more frequent in the first dose than second dose in AZ vaccine; more frequent in the second dose in Moderna or Pfizer/BNT vaccine. Taiwan V-watch is a system monitored by CDC for people proactive notification of side effects post COVID-19 vaccination. But it doesn't include the objective cardiovascular parameters, for example, heart rate, arrhythmia, blood pressure, central body temperature (ear temperature) and blood oxygen saturation level. This study aims to monitor the physiologic and psychologic effects, and side effects before and after COVID-19 vaccination in patients at high cardiovascular risk, including hypertension, hyperlipidemia, and type 2 diabetes, and arrhythmia or coronary artery disease. The investigators arrange two weeks of continuous home BP/HR monitoring (7 days pre- and post-vaccination) for evaluation of physiologic effects post vaccination. Due to fever noted in some people post-vaccination, the investigators also measure ear temperature, pulse oximetry, and environmental temperature and humidity, for the reference of BP monitoring. In conclusion, this study may provide important information of cardiovascular response and psychosocial effects after SARS-CoV-2 vaccination for proactive prevention of cardiovascular complications.

NCT ID: NCT05031377 Not yet recruiting - Clinical trials for Cardiovascular Diseases

Effects of Cardiovascular Health Education Program on Community-dwelling Older Adults at Risk of ASCVD

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

Despite older adults being exposed to an increased risk of atherosclerotic cardiovascular disease (ASCVD), they are generally underrepresented in cardiovascular prevention programmes. The aim of this study is to assess the feasibility of implementing an integrated exercise and cardiovascular health education programme (HE programme) on older adults at risk of ASCVD.